4 completed. 3 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
| Phase 2 | 3 | Completed 3 |
Follow ESBATech AG: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Exploratory Study on Topical ESBA105 in Acute Anterior Uveitis ESBA105 - Anterior Uveitis | Phase 2 | Completed | ESBATech AG | 9 | 2009-01-01 | 2011-05-26 |
| Ocular Biodistribution Study for Topically Applied ESBA105 Placebo - Cataract | Phase 1 / Phase 2 | Completed | ESBATech AG | 79 | 2009-01-01 | 2010-09-24 |
| Study of Intra-articular DLX105 Applied to Patients With Severely Painful Osteoarthritis of the Knee DLX105, a single-chain (scFv) antibody fragment against TNF-alpha, Placebo - Osteoarthritis | Phase 1 / Phase 2 | Completed | ESBATech AG | 27 | 2008-12-01 | 2010-09-24 |
| Study of ESBA105 Eye Drops in Healthy Subjects ESBA105 - Healthy | Phase 1 | Completed | ESBATech AG | 27 | 2008-04-01 | 2008-08-25 |
Cataract (1) · Macular Edema (1) · Osteoarthritis (1) · Pain (1) · Uveitis (1) · Uveitis, Anterior (1)
ESBA105 (2)
Switzerland (3) · Germany (2)
Manfred Zierhut, MD (1) · Michael A Thiel, MD, PhD (1) · PD.Dr. Diego Kyburz, MD (1) · Prof. Georg Schett, MD (1)